SV

Street Verdict

Analyst Scorecard

A record of what Hitesh Tailor said publicly, with the source. Not advice.

“Bullish on Ajanta Pharma for the next 1-2 weeks, recommending a buy at ₹2,610.70 with a target of ₹2,880 and a stop loss at ₹2,470. The stock has been consolidating, indicating a potential base formation. Further details on the rationale and specific technical indicators are expected to support this bullish outlook.”

Hitesh Tailor’s track record (trackable calls only): 15 graded calls · 95% CI 1–30%

Ajanta PharmaBullishCalled 05 Nov 2025Graded 18 Nov 2025
Verdict:MISS

How this call is judged

A call is judged on closing prices only: a close at its target is a hit and a close at its stop is a miss. A call that states an entry starts at the first close that reaches it; if none does in the days allowed, it was never triggered, is not graded and counts toward no hit rate.

Entry: ₹2,610.7, as stated.

Target ₹2,880, stop ₹2,470, as stated.

Window: 14 days, the time frame the call states ("1-2 weeks").

The stop ₹2,470 was reached on a close before the target ₹2,880. Miss.

The grader’s working: R3 TRADE_SETUP: entered ₹2610.7 on 2025-11-06 (stated entry ₹2610.7, LEVEL_CMP entry, filled); stop ₹2470 breached at close ₹2458.1 on 2025-11-18. Window 14 days — rule H1: the quote states "1-2 weeks".

How it played out

How this is worked out
Target or stop first
The stop was reached on a close before the target was.
Time to target
The target was not reached on a close inside the window.
Worst close against it
The closing price went as far as 5.85% against the call up to 18 Nov 2025, when the call was decided, measured from the entry price. Closing prices only; an intraday dip is never counted.

From the entry the grade used, on closing prices. This is a record of one past call and is not advice.

Tracking Ajanta Pharma since this call

1-year tracking window
Read the original articleSee Hitesh Tailor’s full track record